How Advances in T-Cell Receptor Profiling Can Boost Early Cancer Diagnosis
New developments in flow cytometry and molecular biology promise to improve the detection of rare cancers
Author Information
Brice Ezzouaouy
Brice Ezzouaouy is an expert in clinical flow cytometry with more than 15 years of experience in life sciences research and diagnostic instrumentation. As senior product manager at Beckman Coulter Life Sciences, he is based at the company’s development and manufacturing center in Marseille and oversees global market research and new product launches.
Posts by the Author